Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase
- PMID: 7647793
- DOI: 10.1038/ng0595-61
Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase
Abstract
Recent reports have shown heterozygosity for some twenty different mutations in the CuZn-superoxide dismutase (CuZn-SOD) gene in familial amyotrophic lateral sclerosis (FALS), and analysed samples from patients have shown decreased enzymic activity. Here we report homozygosity for an exon 4 mutation, Asp90Ala in fourteen patients among four unrelated ALS families and four apparently sporadic ALS patients from Sweden and Finland. The erythrocyte CuZn-SOD activity is essentially normal. Our findings suggest that this CuZn-SOD mutation causes ALS by a gain of function rather than by loss, and that the Asp90Ala mutation is less detrimental than previously reported mutations.
Similar articles
-
Mutations in all five exons of SOD-1 may cause ALS.Ann Neurol. 1998 Mar;43(3):390-4. doi: 10.1002/ana.410430319. Ann Neurol. 1998. PMID: 9506558
-
Copper/zinc superoxide dismutase 1 and sporadic amyotrophic lateral sclerosis: analysis of 155 cases and identification of a novel insertion mutation.Ann Neurol. 1997 Nov;42(5):803-7. doi: 10.1002/ana.410420518. Ann Neurol. 1997. PMID: 9392581
-
Variance of age at onset in a Japanese family with amyotrophic lateral sclerosis associated with a novel Cu/Zn superoxide dismutase mutation.Ann Neurol. 1995 May;37(5):676-9. doi: 10.1002/ana.410370518. Ann Neurol. 1995. PMID: 7755363
-
[Amyotrophic lateral sclerosis and superoxide dismutase--a review].Ugeskr Laeger. 1997 Mar 10;159(11):1593-6. Ugeskr Laeger. 1997. PMID: 9092140 Review. Danish.
-
[Familial amyotrophic lateral sclerosis and mutations in the Cu/Zn superoxide dismutase gene].Rinsho Shinkeigaku. 1995 Dec;35(12):1546-8. Rinsho Shinkeigaku. 1995. PMID: 8752459 Review. Japanese.
Cited by
-
Epigenetics in the formation of pathological aggregates in amyotrophic lateral sclerosis.Front Mol Neurosci. 2024 Sep 3;17:1417961. doi: 10.3389/fnmol.2024.1417961. eCollection 2024. Front Mol Neurosci. 2024. PMID: 39290830 Free PMC article. Review.
-
Tofersen decreases neurofilament levels supporting the pathogenesis of the SOD1 p.D91A variant in amyotrophic lateral sclerosis patients.Commun Med (Lond). 2024 Jul 25;4(1):150. doi: 10.1038/s43856-024-00573-0. Commun Med (Lond). 2024. PMID: 39054363 Free PMC article.
-
Variability in SOD1-associated amyotrophic lateral sclerosis: geographic patterns, clinical heterogeneity, molecular alterations, and therapeutic implications.Transl Neurodegener. 2024 May 29;13(1):28. doi: 10.1186/s40035-024-00416-x. Transl Neurodegener. 2024. PMID: 38811997 Free PMC article. Review.
-
Ebselen analogues delay disease onset and its course in fALS by on-target SOD-1 engagement.Sci Rep. 2024 May 27;14(1):12118. doi: 10.1038/s41598-024-62903-5. Sci Rep. 2024. PMID: 38802492 Free PMC article.
-
Insights on the Multifaceted Roles of Wild-Type and Mutated Superoxide Dismutase 1 in Amyotrophic Lateral Sclerosis Pathogenesis.Antioxidants (Basel). 2023 Sep 10;12(9):1747. doi: 10.3390/antiox12091747. Antioxidants (Basel). 2023. PMID: 37760050 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous